Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

• Main Authors: Lim, Jasmine, Amantakul, Akara, Shariff, Nisha, Lojanapiwat, Bannakij, Alip, Adlinda, Ong, Teng Aik, Thevarajah, Shankaran, Ahmayuddin, Firdaus, Mathew, Adeline, Sriplakich, Supon, Vuthiwong, Jaraspong, Chong, Flora Li Tze, Saad, Marniza
• Format: Article
• Published: Wiley Open Access 2020
• Subjects: RD Surgery
• Online Access: http://eprints.um.edu.my/36695/

It is of much interest to understand the efficacy of abiraterone acetate (AA) in routine clinical practice. We assessed the clinical outcome of AA in patients with metastatic castration-resistant prostate cancer (mCRPC) and determined clinical factors associated with AA treatment duration in real-wo...